CRISPR THERAPEUTICS AG COM CHF0.03 earnings per share and revenue

0VRQ earnings per share for the last quarter are -1.49 USD whereas the estimation was -1.43 USD which accounts for -4.38% surprise. Company revenue for the same period amounts to 517.00 k USD despite the estimated figure of 12.06 M USD. Estimated earnings per share for the next quarter are -1.42 USD, and revenue is expected to reach 6.65 M USD. Also watch annual changes over time to get a bigger picture of 0VRQ earnings per share and revenue dynamics.